Funded Tech Companies

Courage Therapeutics

Courage Therapeutics, based in Ann Arbor, received equity investments through Arsenal Venture Partners and private investors.

Company Overview

Company Name
Courage Therapeutics
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
Undisclosed
Ann Arbor, MI Undisclosed
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Courage Therapeutics is a leading neuroendocrine company co-founded by Dr. Roger Cone, a pioneering researcher in melanocortin receptor biology and the central melanocortin system's neural circuits in the brain. The company is dedicated to translating Dr. Cone's decades of work and discoveries of novel biological mechanisms of energy homeostasis into novel therapeutic candidates targeting the MC4R and MC3R receptors.
Profile
Courage Therapeutics LinkedIn Company Profile
Social Media
Courage Therapeutics Company Twitter Account
Company News
Courage Therapeutics News
Facebook
Courage Therapeutics on Facebook
YouTube
Courage Therapeutics on YouTube
Last Transaction
11/3/2025

Financing History

Date
Type
Amount
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chief Executive Officer
Giovanni Ferrara
  Giovanni Ferrara LinkedIn Profile  Giovanni Ferrara Twitter Account  Giovanni Ferrara News  Giovanni Ferrara on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Cour Pharmaceuticals | coUrbanize

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary